Acute Ischemic Stroke companies working in the treatment market are Acticor Biotech, Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others, are developing therapies for ...

DelveInsight’s, “Ischemic Stroke Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 55+ ...

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when ...

Just 14 patients need screening with extended CT angiography to find one clot, according to the DAYLIGHT study, improving ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.

DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ...

We divide the term stroke into two general categories: ischemic and hemorrhagic. Ischemic Stroke An ischemic stroke is a clot-based stroke that forms in the brain or elsewhere in the body and blocks ...

Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice. Journal of Clinical Investigation, 2021; 131 (17) DOI: 10.1172/JCI144898 ...

Five-year View Overall thrombolysis rates for acute ischemic stroke will continue to increase as pre- and in-hospital management improves by creating widely available brain-attack networks ...

CHI St. Alexius Dickinson earns American Heart Association’s Rural Stroke Gold Achievement Award, recognizing the hospital’s excellence in treating strokes across southwest North Dakota.

Endovascular thrombectomy (EVT) is a highly effective treatment for acute ischemic stroke due to large-vessel occlusion, 1,5 even among patients with extensive ischemic changes at baseline. 6 Data ...

While mechanical thrombectomy is considered an excellent treatment option for ischemic stroke, it is drastically underutilized as a first line treatment for stroke, with less than 20 percent of ...